ANIK Live-Signale | Maximieren Sie Profite mit Getagraph.com

VERKAUFEN 108315 min ago

@ $23.63

Ausgestellt: 14 Feb 2024 @ 15:30

Rendite: 9.84%

Vorheriges Signal: Feb 13 - 15:30

Vorheriges Signal: Kaufen

Rendite: 0.60 %

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 21:36):

Stats
Tagesvolumen	22 961.00
Durchschnittsvolumen	80 045.00
Marktkapitalisierung	385.43M
EPS	$0 ( 2024-03-13 )
Nächstes Ertragsdatum	( $-0.190 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.60
ATR14	$0.0570 (0.22%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-15	Levitz Michael L	Buy	51 682	Stock Option (Right to Buy)
2024-03-15	Levitz Michael L	Buy	21 329	Restricted Stock Unit
2024-03-15	Colleran David	Buy	46 875	Stock Option (Right to Buy)
2024-03-15	Colleran David	Buy	19 345	Restricted Stock Unit
2024-03-15	Nunes Anne	Buy	26 442	Stock Option (Right to Buy)

INSIDER POWER
51.59
Last 100 transactions
Buy: 1 044 875 \| Sell: 338 384

Volumen Korrelation

Lang: -0.09 (neutral)

Kurz: -0.61 (weak negative)

Signal:(51.254) Neutral

Anika Therapeutics Inc Korrelation

10 Am meisten positiv korreliert
RMRM	0.905
BPTH	0.892
GOODN	0.886
RMGC	0.883
MLVF	0.875
BCOV	0.872
ALLT	0.87
WISH	0.868
GOODO	0.868
APTX	0.868

10 Am meisten negativ korreliert
PTRS	-0.908
AAON	-0.874
ULBI	-0.866
CORT	-0.859
PXI	-0.855
STEP	-0.842
PSCE	-0.84
TUR	-0.838
GSHD	-0.837
FTXN	-0.837

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Anika Therapeutics Inc Korrelation - Währung/Rohstoff

0.76
( moderate )

0.82
( strong )

0.00
( neutral )

0.61
( weak )

-0.30
( neutral )

-0.70
( moderate negative )

Anika Therapeutics Inc Finanzdaten

Annual	2023
Umsatz:	$166.66M
Bruttogewinn:	$103.09M (61.85 %)
EPS:	$-5.64

FY	2023
Umsatz:	$166.66M
Bruttogewinn:	$103.09M (61.85 %)
EPS:	$-5.64

FY	2022
Umsatz:	$156.24M
Bruttogewinn:	$93.58M (59.89 %)
EPS:	$-1.020

FY	2021
Umsatz:	$147.79M
Bruttogewinn:	$82.94M (56.12 %)
EPS:	$0.290

Financial Reports:

No articles found.

Anika Therapeutics Inc

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management product family consists of Monovisc, Orthovisc, Cingal, and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions; and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products, a line of sports medicine soft tissue repair solutions, and orthopedic regenerative solutions products. The company's non-orthopedic product family include HA-based products for non-orthopedic applications, including adhesion barrier products, advanced wound care products, ophthalmic products, and ear, nose, and throat products. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.